Meet DCN Dx's Experts and Discover the miniDxR Customizable
Lateral Flow Reader at Booth 2468
CARLSBAD, Calif., July 11,
2024 /PRNewswire/ -- DCN Dx, a global leader in IVD
CDMO and CRO services, is excited to announce their participation
in the ADLM Annual Meeting 2024 (formerly AACC) from July 28 to August 1 at the McCormick Place
Convention Center in Chicago, IL.
Attendees are invited to visit DCN Dx at booth 2468 to explore
their latest innovations and join their poster presentation on
quantitative bacteriology parameters.
DCN Dx will have representatives from their assay development,
engineering, clinical research, and manufacturing teams on hand to
answer questions and discuss their comprehensive services. This
multidisciplinary approach ensures that DCN Dx can support every
stage of IVD product development, from concept through to
manufacturing, including IVD clinical trials with particular
expertise in point-of-care testing.
Attendees can also experience the miniDxR, a state-of-the-art
customizable lateral flow assay reader, at the DCN Dx booth.
Designed by DCN Dx for point-of-care testing, the miniDxR offers
advanced imaging technology, superior sensitivity and specificity,
and robust cybersecurity features, making it an ideal solution for
a variety of settings.
The poster presentation will examine the performance of InTray®
Mueller Hinton Chocolate and Colorex™ Screen agar plates under
stress conditions mimicking low-resource tropical field clinics.
This study, presented by Brandon
Font, Research Scientist and Technical Services Manager at
Biomed Diagnostics, a DCN Dx brand, and Pat
Vaughan, Ph.D., COO of DCN Dx, evaluates the plates' ability
to maintain bacterial viability and diagnostic accuracy over
extended periods.
"We are excited to be back at the ADLM Annual Meeting this
year," said Charlie Mamrak, CEO of
DCN Dx. "Our poster presentation and the presence of our
multidisciplinary team highlight our commitment to advancing
diagnostic technologies for the clients we serve."
"Having our experts at the ADLM Annual Meeting allows us to host
in-depth conversations in our booth," said Mitzi Rettinger, Chief Revenue Officer of DCN
Dx. "Our team is ready to share how our services reduce risk for
our clients' IVD programs and improve patient outcomes."
"Our research on the performance of InTray® agar plates under
challenging conditions demonstrates our dedication to supporting
diagnostic solutions in diverse conditions," said Dr. Pat Vaughan. "We look forward to discussing our
findings with fellow attendees."
About DCN Dx
DCN Dx, based in Carlsbad,
California, is a global leader in IVD CDMO and CRO services.
Our multidisciplinary CDMO specializes in creating tailored assay
systems, consumables, and instruments for point-of-use
applications, with a particular expertise in lateral flow assays.
Our clinical research services group specializes in the planning,
execution, and oversight of IVD clinical trials, inclusive of
clinical operations, data management, and biostatistics.
Our personalized approach to IVD product development and
clinical trials has supported hundreds of programs and clients. We
can oversee every stage from concept to assay development and
platform integration, through clinical trials to manufacturing or
only handle the aspects you request. In addition to lateral flow
assays, our clinical research expertise extends to a wide range of
IVD devices, all with a focus on innovation, usability, and
performance.
With a commitment to quality, customer satisfaction, and
industry-leading expertise, DCN Dx is setting the benchmark for
excellence in IVD services. To learn more about how we can support
your diagnostic needs, visit dcndx.com.
For more information contact:
Mitzi Rettinger
Chief Revenue Officer, DCN Dx
Main: (760) 804-3886
Mobile: (512) 431-5836
380290@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dcn-dx-to-showcase-new-technologies-and-present-critical-research-at-adlm-2024-302194766.html
SOURCE DCN Dx